BioCentury
ARTICLE | Clinical News

Jerini Phase IIa liver cirrhosis data

December 2, 2003 8:00 AM UTC

Jerini (Berlin, Germany) said that in a cross-over, double-blind, placebo-controlled Swiss Phase IIa trial in 8 healthy volunteers and 8 patients with refractory ascites in liver cirrhosis, Icatibant ...